{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:25:12Z","timestamp":1791563112500,"version":"4.3.4"},"reference-count":50,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8J0361"],"award-info":[{"award-number":["CMRPG8J0361"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The trends in hormone indices of children with attention deficit hyperactivity disorder (ADHD) who received long-term medication treatment remains controversial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This prospective study aimed to examine the changes in the growth hormone and thyroid hormone systems among children with ADHD undergoing various medication treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In total, 118 children who were diagnosed with ADHD and were drug-naive were observed naturalistically over 12 months. Of them, 22 did not receive any medication, while 39, 40, and 17 were treated with low doses of short-acting methylphenidate (MPH) (14\u2005\u00b1\u20056.7 mg\/day), osmotic-release oral system (OROS) long-acting MPH (32\u2005\u00b1\u20059.6 mg\/day), and atomoxetine (29.2\u2005\u00b1\u20059.7 mg\/day), respectively. Blood samples were obtained at both the baseline and the endpoint (month 12) to measure serum levels of insulin-like growth factor 1 (IGF-1), IGF binding protein 3 (IGFBP-3), prolactin, thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), and free T4.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Trends for IGF-1, IGFBP-3, prolactin, TSH, T3, T4, and free T4 levels were similar among the 4 groups. Changes in serum levels of IGF-1 were positively correlated with changes in height and weight of all the children with ADHD. However, patients who received MPH treatment had less body weight gain than the nonmedicated group. The ratio of MPH doses to body weight was inversely correlated with the increment in height.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>There were no changes in thyroid or growth hormones associated with the low doses of ADHD medications used in this study within 1 year\u2019s duration. Nonetheless, patients\u2019 growth and the appropriateness of drug dosage should be closely monitored.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac139","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T10:49:43Z","timestamp":1646822983000},"page":"2047-2056","source":"Crossref","is-referenced-by-count":12,"title":["Growth Hormone and Thyroid Function in Children With Attention Deficit Hyperactivity Disorder Undergoing Drug Therapy"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-1151","authenticated-orcid":false,"given":"Liang-Jen","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine , Kaohsiung , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine , Kaohsiung , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jiun","family":"Chou","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine , Kaohsiung , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-9643","authenticated-orcid":false,"given":"Sheng-Yu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kaohsiung Veterans General Hospital , Kaohsiung , Taiwan"},{"name":"Department of Psychiatry, College of Medicine, Graduate Institute of Medicine, School of Medicine, Kaohsiung Medical University , Kaohsiung , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"issue":"10222","key":"2022061616034727600_CIT0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(19)33004-1","article-title":"Attention-deficit hyperactivity disorder","volume":"395","author":"Posner","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"2022061616034727600_CIT0002","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics"},{"key":"2022061616034727600_CIT0003","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1017\/S2045796018000793","article-title":"Prevalence of DSM-5 mental disorders in a nationally representative sample of children in Taiwan: methodology and main findings","volume":"29","author":"Chen","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2022061616034727600_CIT0004","first-page":"e20192528","article-title":"Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume-title":"Pediatrics","author":"Wolraich","year":"2019"},{"key":"2022061616034727600_CIT0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"issue":"9","key":"2022061616034727600_CIT0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"2022061616034727600_CIT0007","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s40263-014-0175-1","article-title":"review of OROS methylphenidate (Concerta((R))) in the treatment of attention-deficit\/hyperactivity disorder","volume":"28","author":"Katzman","year":"2014","journal-title":"CNS Drugs"},{"key":"2022061616034727600_CIT0008","first-page":"215","article-title":"Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder in children and adolescents: a review","volume":"5","author":"Hammerness","year":"2009","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"8","key":"2022061616034727600_CIT0009","doi-asserted-by":"crossref","first-page":"e0161061","DOI":"10.1371\/journal.pone.0161061","article-title":"Initiation and persistence of pharmacotherapy for youths with attention deficit hyperactivity disorder in Taiwan","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One."},{"key":"2022061616034727600_CIT0010","first-page":"CD012069","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","volume":"5","author":"Storebo","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"issue":"120","key":"2022061616034727600_CIT0011","first-page":"238","article-title":"Growth retardation","volume":"20","author":"Methylphenidate","year":"2011","journal-title":"Prescrire Int."},{"issue":"4","key":"2022061616034727600_CIT0012","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1542\/peds.2013-3427","article-title":"Attention deficit disorder, stimulant use, and childhood body mass index trajectory","volume":"133","author":"Schwartz","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"2022061616034727600_CIT0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12888-018-1884-7","article-title":"Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)","volume":"18","author":"McCarthy","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"8","key":"2022061616034727600_CIT0014","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaac.2019.06.019","article-title":"Trajectories of growth associated with long-term stimulant medication in the multimodal treatment study of attention-deficit\/hyperactivity disorder","volume":"59","author":"Greenhill","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"2022061616034727600_CIT0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neubiorev.2020.09.031","article-title":"Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis","volume":"120","author":"Carucci","year":"2021","journal-title":"Neurosci Biobehav Rev."},{"issue":"6","key":"2022061616034727600_CIT0016","doi-asserted-by":"crossref","first-page":"649","DOI":"10.30773\/pi.2018.02.25.1","article-title":"Effects of atomoxetine on height and weight in Korean children and adolescents with attention-deficit\/hyperactivity disorder: a retrospective chart review","volume":"15","author":"Kweon","year":"2018","journal-title":"Psychiatry Investig"},{"issue":"7","key":"2022061616034727600_CIT0017","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40263-016-0349-0","article-title":"The safety of atomoxetine for the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a comprehensive review of over a decade of research","volume":"30","author":"Reed","year":"2016","journal-title":"CNS Drugs"},{"issue":"7","key":"2022061616034727600_CIT0018","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/cap.2012.0086","article-title":"Attention-deficit\/hyperactivity disorder drugs and growth: an Italian prospective observational study","volume":"23","author":"Germinario","year":"2013","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"3","key":"2022061616034727600_CIT0019","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S1461145713001132","article-title":"Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination","volume":"17","author":"Hysek","year":"2014","journal-title":"Int J Neuropsychopharmacol."},{"issue":"1","key":"2022061616034727600_CIT0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/jnp.3.1.41","article-title":"Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder","volume":"3","author":"Lurie","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"2022061616034727600_CIT0021","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/1381612822666151124235816","article-title":"Psychopharmacology of attention-deficit hyperactivity disorder: effects and side effects","volume":"22","author":"Golmirzaei","year":"2016","journal-title":"Curr Pharm Des."},{"key":"2022061616034727600_CIT0022","doi-asserted-by":"crossref","first-page":"1178626419842176","DOI":"10.1177\/1178626419842176","article-title":"The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system","volume":"12","author":"Lewitt","year":"2019","journal-title":"Biochem Insights"},{"issue":"6","key":"2022061616034727600_CIT0023","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1530\/EC-18-0099","article-title":"The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders","volume":"7","author":"Blum","year":"2018","journal-title":"Endocr Connect"},{"issue":"3","key":"2022061616034727600_CIT0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00002826-199706000-00011","article-title":"Lack of effect of methylphenidate on serum growth hormone (GH), GH-binding protein, and insulin-like growth factor I","volume":"20","author":"Toren","year":"1997","journal-title":"Clin Neuropharmacol."},{"issue":"4","key":"2022061616034727600_CIT0025","first-page":"159","article-title":"Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment","volume":"63","author":"Bereket","year":"2005","journal-title":"Horm Res."},{"key":"2022061616034727600_CIT0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000445147","article-title":"Growth hormone-insulin-like growth factor axis, thyroid axis, prolactin, and exercise","volume":"47","author":"Hackney","year":"2016","journal-title":"Front Horm Res."},{"issue":"1","key":"2022061616034727600_CIT0027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004583-198401000-00008","article-title":"Prolactin, growth hormone and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate","volume":"23","author":"Greenhill","year":"1984","journal-title":"J Am Acad Child Psychiatry"},{"issue":"3","key":"2022061616034727600_CIT0028","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/clinem\/dgaa903","article-title":"Effects of thyroid status on regional brain volumes: a diagnostic and genetic imaging study in UK Biobank","volume":"106","author":"Chambers","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022061616034727600_CIT0029","first-page":"154","article-title":"Preliminary investigation of association between methylphenidate and serum growth markers in children with attention-deficit\/hyperactivity disorder: a cross-sectional case-control study","volume":"31","author":"Kim","year":"2020","journal-title":"Soa Chongsonyon Chongsin Uihak"},{"issue":"6","key":"2022061616034727600_CIT0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.beem.2009.08.003","article-title":"Drugs that suppress TSH or cause central hypothyroidism","volume":"23","author":"Haugen","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"2022061616034727600_CIT0031","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. 5th ed. (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"2022061616034727600_CIT0032","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpr.7","article-title":"ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument","volume":"14","author":"Zhang","year":"2005","journal-title":"Int J Methods Psychiatr Res."},{"issue":"5","key":"2022061616034727600_CIT0033","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/09297040590951587","article-title":"Test review: Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV)","volume":"11","author":"Baron","year":"2005","journal-title":"Child Neuropsychol."},{"key":"2022061616034727600_CIT0034","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fnagi.2018.00268","article-title":"Visual attention performances and related cerebral microstructural integrity among subjects with subjective cognitive decline and mild cognitive impairment","volume":"10","author":"Tu","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"2022061616034727600_CIT0035","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.3389\/fpsyg.2018.02747","article-title":"Attention improves during physical exercise in individuals with ADHD","volume":"9","author":"Rassovsky","year":"2018","journal-title":"Front Psychol."},{"issue":"8","key":"2022061616034727600_CIT0036","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1177\/1087054719887433","article-title":"Validity of visual and auditory attention tests for detecting ADHD","volume":"25","author":"Wang","year":"2021","journal-title":"J Atten Disord."},{"key":"2022061616034727600_CIT0037","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-244X-11-70","article-title":"Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"235","key":"2022061616034727600_CIT0038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child."},{"issue":"239","key":"2022061616034727600_CIT0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child."},{"key":"2022061616034727600_CIT0040","author":"WHO"},{"key":"2022061616034727600_CIT0041","article-title":"ADHD-RS inattention scores and ADHD-RS hyperactivity\/impulsivity scores among the four groups at the baseline (month 0, V1) and the endpoint (month 12, V2),","author":"Wang","year":"2022","journal-title":"Mendeley Data"},{"issue":"1","key":"2022061616034727600_CIT0042","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2011.03.015","article-title":"Stimulants and growth in children with attention-deficit\/hyperactivity disorder","volume":"77","author":"Negrao","year":"2011","journal-title":"Med Hypotheses."},{"key":"2022061616034727600_CIT0043","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13817","article-title":"Correlation between attention-deficit\/hyperactivity disorder, its pharmacotherapy and thyroid dysfunction: A nationwide population-based study in Taiwan","author":"Chen","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2022061616034727600_CIT0044","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpeds.2010.04.025","article-title":"A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects","volume":"157","author":"Biederman","year":"2010","journal-title":"J Pediatr."},{"issue":"6","key":"2022061616034727600_CIT0045","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1592\/phco.29.6.656","article-title":"Attention-deficit-hyperactivity disorder: an update","volume":"29","author":"Dopheide","year":"2009","journal-title":"Pharmacotherapy."},{"issue":"6","key":"2022061616034727600_CIT0046","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40263-020-00725-5","article-title":"Dose adjustment of stimulants for children with attention-deficit\/hyperactivity disorder: a retrospective chart review of the impact of exceeding recommended doses","volume":"34","author":"Ross","year":"2020","journal-title":"CNS Drugs"},{"issue":"6","key":"2022061616034727600_CIT0047","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jcpp.12684","article-title":"Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit\/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression","volume":"58","author":"Swanson","year":"2017","journal-title":"J Child Psychol Psychiatry."},{"issue":"8","key":"2022061616034727600_CIT0048","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1089\/cap.2016.0150","article-title":"Weight, height, and body mass index in patients with attention-deficit\/hyperactivity disorder treated with methylphenidate","volume":"27","author":"Diez-Suarez","year":"2017","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"8","key":"2022061616034727600_CIT0049","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/cap.2017.0163","article-title":"Psychostimulants: influence on body mass index and height in a pediatric population with attention-deficit\/hyperactivity disorder?","volume":"28","author":"Lentferink","year":"2018","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"2","key":"2022061616034727600_CIT0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004583-200102000-00012","article-title":"Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial","volume":"40","author":"Greenhill","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac139\/43138101\/dgac139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/7\/2047\/44110724\/dgac139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/7\/2047\/44110724\/dgac139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T16:11:37Z","timestamp":1655395897000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/7\/2047\/6545254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,3,9]]},"published-print":{"date-parts":[[2022,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac139","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,3,9]]}}}